Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmos/Pharmatec merger

Executive Summary

President and COO of the combined companies will be Pharmos co- Chairman Stephen Streber, who joins Pharmos from biotech start-up Innovir where he was president and CEO. Prior to Innovir, Streber was president of Roussel-Uclaf's U.S. operations. In addition, Henry Dachowitz joins the soon-to-be merged companies from Richard A. Eisner & Co. as chief financial officer. A definitive merger agreement was announced by Israeli firm Pharmos and Gainesville, Fla.-based Pharmatec in May as well as an option to acquire Xenon Vision ("The Pink Sheet" May 18, T&G-10).
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021317

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel